Bad can act as a key regulator of T cell apoptosis and T cell development

Journal of Experimental Medicine

Volumn 189, Issue 3, 1999, Pages 575-586

  Mok, Chen Lang ^a   Gil Gómez, Gabriel ^b   Williams, Owen ^a   Coles, Mark ^a   Taga, Samir ^a   Tolaini, Mauro ^a   Norton, Trisha ^a   Kioussis, Dimitris ^a   Brady, Hugh J M ^a,c  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Akt; Apoptosis; Bad; Cell cycle; Selection

Indexed keywords

ANTIBODY; FAS ANTIGEN; INTERLEUKIN 2; PHOSPHOTRANSFERASE; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE B; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENIC MOUSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD95; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CELL CYCLE; DEXAMETHASONE; GAMMA RAYS; HOMEODOMAIN PROTEINS; INTERLEUKIN-12; MICE; MICE, TRANSGENIC; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND; UP-REGULATION;

EID: 0345129987     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.3.575     Document Type: Article

References (51)

1. von Boehmer, H. 1994. Positive selection of lymphocytes. Cell. 76:219-228.
2. Surh, C.D., and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 372:100-103.
3. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
4. Strasser, A., D.C. Huang, and D.L. Vaux. 1997. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochem. Biophys. Acta. 1333: F151-F178.
5. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:440-442.
6. Strasser, A., A.W. Harris, D.C. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO (Eur. Mol. Biol. Organ.) J. 14:6136-6147.
7. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Ann. Rev. Immunol. 13:513-543.
8. Kelekar, A., and C.B. Thompson. 1998. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8:324-330.
9. Sentman, C.L., J.R. Shutter, D. Hockenbery, O. Kanagama, and S.J. Korsmeyer. 1991. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67: 879-888.
10. Strasser, A., A.W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
11. Strasser, A., A.W. Harris, H. von Boehmer, and S. Cory. 1994. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc. Natl. Acad. Sci. USA 91:1376-1380.
12. + thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus. J. Exp. Med. 179:145-153.
13. Williams, O., T. Norton, M. Halligey, D. Kioussis, and H.J.M. Brady. 1998. The action of Bax and bcl-2 in T cell selection. J. Exp. Med. 188:1125-1133.
14. Yang, E., J. Zha, J. Jockel, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer. 1995. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:285-291.
15. Kitada, S., M. Krajewska, X. Zhang, D. Scudiero, J.M. Zapata, H.G. Wang, A. Shabaik, G. Tudor, S. Krajewski, T.G. Myers, et al. 1998. Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol. 152:51-61.
16. Ottilie, S., J.L. Diaz, W. Horne, J. Chang, Y. Wang, G. Wilson, S. Chang, S. Weeks, L.C. Fritz, and T. Oltersdorf. 1997. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J. Biol. Chem. 272:30866-30872.
17. Zha, J., H. Harada, K. Osipov, J. Jockel, G. Waksman, and S.J. Korsmeyer. 1997. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J. Biol. Chem. 272:24101-24104.
18. Kelekar, A., B.S. Chang, J.E. Harlan, S.W. Fesik, and C.B. Thompson. 1997. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol. 17:7040-7046.
19. Zha, J., H. Harada, E. Yang, J. Jockel, and S.J. Korsmeyer. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X. Cell. 87:619-628.
20. Wang, H.G., U.R. Rapp, and J.C. Reed. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:629-638.
21. Hsu, S.Y., A. Kaipia, L. Zhu, and A.J. Hsueh. 1997. Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Mol. Endocrinol. 11:1858-1867.
22. Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:231-241.
23. del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:687-689.
24. Alessi, D.R., and P. Cohen. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genes Dev. 8:55-62.
25. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods. 185:133-140.
26. Nicoletti, I., G. Miglioratti, M.C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:271-279.
27. Brady, H.J.M., G. Gil-Gomez, J. Kirberg, and A.J.M. Berns. 1996. Baxα perturbs T cell development and affects cell cycle entry of T cells. EMBO (Eur. Mol. Biol. Organ.) J. 15:6991-7001.
28. Cobbold, S.P., A. Jayasuriya, A. Nash, T.D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature, 312:548-551.
29. b11-positive mouse T-cell clone. Immunogenetics. 28:445-451.
30. Lang, G., D. Wotton, M.J. Owen, W.A. Sewell, M.H. Brown, D.Y. Mason, M.J. Crumpton, and D. Kioussis. 1988. The structure of the human CD2 gene and its expression in transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 7:1675-1682.
31. Greaves, D.R., F.D. Wilson, G. Lang, and D. Kioussis. 1989. Human CD2 3′-flanking sequences confer high level, T cell-specific, position independent gene expression in transgenic mice. Cell. 56:979-986.
32. Brady, H.J.M., G.S. Salomons, R.C. Bobeldijk, and A.J.M. Berns. 1996. T cells from baxα transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. EMBO (Eur. Mol. Biol. Organ.) J. 15:1221-1230.
33. Zhang, X., L. Li, J. Choe, S. Krajewski, J.C. Reed, C. Thompson, and Y.S. Choi. 1996. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell. Immunol. 173:149-154.
34. Medema, J.P., C. Scaffidi, P.H. Krammer, and M.E. Peter. 1998. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J. Biol. Chem. 273: 3388-3393.
35. Cohen, J.J., R.C. Duke, V.A. Fadsk, and K.S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol. 10:267-293.
36. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
37. Mamalaki, C., T. Norton, Y. Tanaka, A.R. Townsend, P. Chandler, E. Simpson, and D. Kioussis. 1992. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 89: 11342-11346.
38. Spanopoulou, E., C.A.J. Roman, L.M. Corcoran, M.S. Schlissel, D.P. Silver, D. Nemazee, M.C. Nussenzwieg, S.A. Shinton, R.R. Hardy, and D. Baltimore. 1994. Functional immunoglobulin transgenes guide ordered B-cell differentiation in RAG-1 deficient mice. Genes Dev. 8:1030-1042.
39. Townsend, A.R., A.J. McMichael, N.P. Carter, J.A. Huddleston, and G.G. Brownlee. 1984. Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell. 39:13-25.
40. Yao, R., and G.M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:2003-2006.
41. Franke, T.F., and L.C. Cantley. 1997. Apoptosis. A Bad kinase makes good. Nature. 390:116-117.
42. Franke, T.F., S.I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, D.K. Morrison, D.R. Kaplan, and P.N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727-736.
43. Brennan, P., J.W. Babbage, B.M.T. Burgering, B. Groner, K. Reif, and D.A. Cantrell. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity. 7:679-689.
44. Linette, G.P., Y. Li, K. Roth, and S.J. Korsmeyer. 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA. 93:9545-9552.
45. O'Reilly, L.A., D.C. Huang, and A. Strasser. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO (Eur. Mol. Biol. Organ.) J. 15:6979-6990.
46. Nourse, J., E. Firpo, W.M. Flanagan, S. Coats, K. Polyak, M.H. Lee, J. Massague, G.R. Crabtree, and J.M. Roberts. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature. 372:570-573.
47. Boise, L.H., A.J. Minn, P.J. Noel, C.H. June, M.A. Accavitti, T. Lindsten, and C.B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:87-89.
48. Schweighoffer, E., and B.J. Fowlkes. 1996. Positive selection is not required for thymic maturation of transgenic γ/δ T cells. J. Exp. Med. 183:2033-2041.
49. Kang, J., M. Coles, D. Cado, and D.H. Raulet. 1998. The development fate of T cells is critically influenced by TCR γδ expression. Immunity. 8:427-438.
50. Ahmed, N.N., H.L. Grimes, A. Bellacosa, T.O. Chan, and P.N. Tsichlis. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:3627-3632.
51. Shibasaki, F., E. Kondo, T. Akagi, and F. McKeon. 1997. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386: 728-731.